Efektivitas Edukasi Obat untuk Pasien Diabetes Mellitus pada Masa Pandemi Covid-19 di Puskesmas Kecamatan Cempaka Putih, Jakarta Pusat
The Effectiveness of Medication Guidance for Diabetes Mellitus Patients during the Covid-19 Pandemic at the Cempaka Putih District Primary Health Care, Central Jakarta
DOI:
https://doi.org/10.25026/jsk.v4i4.1264Keywords:
pharmacist, diabetic education, PROLANIS, HbA1cAbstract
Diabetes mellitus is a chronic disease requires continuous therapy by professional health workers and self-care management from the patients. To support this, diabetic patient who seek treatment at the primary healthcare facilities is recommended to join The Chronic Disease Management Program (Prolanis). During the Covid-19 pandemic, the frequency of diabetic-related prolanis activities became less monitored, especially regarding the accuracy of using antidiabetic oral (ADO). A quasi-experimental study was conducted through drug education by pharmacists to determine the effect of such education on clinical outcomes, namely the patient's glycosylated hemoglobin (HbA1c) levels. The results showed that there was a decrease in HbA1c levels (1.31%) in the intervention group (n=7) and an increase in HbA1c (0.51%) in the control group (n=17; p=0.078). Eventhough it was not statistically significant due to limited research subjects, education on the proper use of ADO can reduce HbA1c levels in diabetic patients.
References
Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018 Apr 1;138:271–81.
World Health Organization. Global Report On Diabetes [Internet]. 2016 [cited 2022 May 15]. Available from: http://www.who.int/about/licensing/copyright_form/index.html
World Health Organization. Diabetes Country Profiles [Internet]. World Health Organization. 2016. Available from: https://www.who.int/diabetes/country-profiles/bra_en.pdf
Badan Penelitian dan Pengembangan Kesehatan. Hasil Utama Riskesdas 2018 [Internet]. 2018. Available from: http://www.depkes.go.id/resources/download/info-terkini/hasil-riskesdas-2018.pdf
Rudijanto A, Yuwono A, Shahab A, Manaf A, Pramono B, Lindarto D, et al. Konsensus Pengelolaan dan Pencegahan Diabetes mellitus tipe 2 di Indonesia. PB. Perkeni; 2015.
American Diabetes Association. Standard medical care in diabetes 2018. J Clin Appl Res Educ. 2018;41(January):1–150.
Nazriati E, Pratiwi D, Restuastuti T. Pengetahuan pasien diabetes melitus tipe 2 dan hubungannya dengan kepatuhan minum obat di Puskesmas Mandau Kabupaten Bengkalis. Maj Kedokt Andalas [Internet]. 2018;41(2):59–68. Available from: http://jurnalmka.fk.unand.ac.id/index.php/art/article/view/561
Larasati LA, Andayani TM, Kristina SA. Hubungan Tingkat Pengetahuan terhadap Outcome Klinik Pasien Diabetes Melitus Tipe 2. J Manaj Dan Pelayanan Farm (Journal Manag Pharm Pract [Internet]. 2019 Jun 24;9(2). Available from: https://jurnal.ugm.ac.id/jmpf/article/view/43489
Yuwindry I, Wiedyaningsih C, Widodo G. Pengaruh Pengetahuan Terhadap Kualitas Hidup Dengan Kepatuhan Penggunaan Obat Sebagai Variabel Antara Pada Pasien Dm. J Manaj dan Pelayanan Farm. 2016;6(4):249–54.
McPherson ML, Smith SW, Powers A, Zuckerman IH. Association between diabetes patients’ knowledge about medications and their blood glucose control. Res Soc Adm Pharm. 2008;4(1):37–45.
Hidayat B, Ramadani RV, Rudijanto A, Soewondo P, Suastika K, Siu Ng JY. Direct Medical Cost of Type 2 Diabetes Mellitus and Its Associated Complications in Indonesia. Value Heal Reg Issues [Internet]. 2022 Mar 1 [cited 2022 May 15];28:82–9. Available from: https://doi.org/10.1016/j.
Nugraheni AY, Sari IP, Andayani TM. Pengaruh Konseling Apoteker Dengan Alat Bantu Pada Pasien Diabetes Melitus. Manaj dan Pelayanan Farm. 2015;5(4):225–32.
Putri WA. Kepuasan Pasien Prolanis terhadap Peran Apoteker di Puskesmas Sleman Yogyakarta. Universitas Islam Indonesia; 2020.
Nurfauzi Y, Nugroho IDW. Pemantauan Apoteker Terhadap Perubahan Obat DM Tipe 2 Pasien Prolanis dengan Partisipasi Edukatif dan Pemetaan Situasi. J Farm Indones. 2021;18(02).
Rasdianah N, Martodiharjo S, Andayani TM, Hakim L, Studi P, Universitas D, et al. Pengaruh Pelayanan Kefarmasian di Rumah pada Pasien Diabetes Melitus Tipe 2 di Puskesmas Wilayah Kota Yogyakarta. 2020;10(2):126–36.
Manninda R, Anggriani Y, Sari AK. Analisis Dampak Program Pengelolaan Penyakit Kronis ( Prolanis ) Dalam Meningkatkan Outcome Klinis Pasien Diabetes Melitus Tipe 2 Di Puskesmas Jakarta, Indonesia. J Ilmu Kefarmasian Indones. 2021;19(2):237–41.
Kim C. Does Menopause increase diabetes risk? Strategies for diabetes prevention in midlife women. Women’s Heal. 2012;8(2):155–67.
Kapur A, Seshiah V. Women & diabetes: Our right to healthy future. Indian J Med Res. 2017;146(5):553–6.
Abdi S, Spann A, Borilovic J, de Witte L, Hawley M. Understanding the care and support needs of older people: a scoping review and categorisation using the WHO international classification of functioning, disability and health framework (ICF). BMC Geriatr. 2019;19(195):1–15.
Pharmaceutical care untuk penyakit diabetes mellitus. Dirjen Bina Kefarmasian dan Alat Kesehatan Kementerian Kesehatan RI; 2005.
Salistyaningsih W, Puspitawati T, Nugroho D. Hubungan Tingkat Kepatuhan Minum Obat Hipoglikemik Oral dengan Kadar Glukosa Darah Pada Pasien DM Tipe 2. Ber Kedokt Masy. 2011;27(4):215–21.
Larasati LA, Andayani TM, Kristina SA, Farmasi F, Mada UG. Hubungan Tingkat Pengetahuan Terhadap Outcome Klinik Pasien Diabetes Melitus Tipe 2. J Manaj dan Pelayanan Farm [Internet]. 2019;9(2):101–8. Available from: https://jurnal.ugm.ac.id/jmpf/article/view/43489/pdf
Sakai R, Hashimoto Y, Ushigome E, Okamura T, Hamaguchi M, Yamazaki M, et al. Understanding of antidiabetic medication is associated with blood glucose in patients with type 2 diabetes: At baseline date of the KAMOGAWA-DM cohort study. J Diabetes Investig. 2019 Mar 1;10(2):458–65.
Hajjar E, Gray S, Slattum P, Starner C, Maher R, Hersh L, et al. Geriatrics. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG PL, editor. Pharmacotherapy: A Pathophysiologic Approach [Internet]. 8th ed. New York: McGraw-Hill Medical; 2014 [cited 2019 Nov 18]. p. 9e. Available from: https://accesspharmacy.mhmedical.com/content.aspx?bookid=689&Sectionid=48811433#57521246
Poolsup N, Suksomboon N, Intarates M. Effect of Pharmacist’s Interventions on Glycemic Control in Diabetic Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Mahidol Univ J Pharm Sci. 2013;40(4):17–30.
Foucault-Fruchard L, Bizzoto L, Allemang-Trivalle A, Renoult-Pierre P, Antier D. Compared benefits of educational programs dedicated to diabetic patients with or without community pharmacist involvement. Prim Heal Care Res Dev. 2020;
Deters MA, Laven A, Castejon A, Doucette WR, Ev LS, Krass I, et al. Effective Interventions for Diabetes Patients by Community Pharmacists: A Meta-analysis of Pharmaceutical Care Components. Ann Pharmacother [Internet]. 2018;52(2):198–211. Available from: https://doi.org/10.1177/1060028017733272
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Jurnal Sains dan Kesehatan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
